In a Lewis lung cancer (LLC) model, knockdown of Cx43 results in reduced T-cell activation, making the tumor less responsive to anti-PD-1 therapy and further exacerbating immunotherapy resistance (46). The gene discussed is GJA1; the disease is neoplasm.